Senti Biosciences (SNTI) Amortizatization of Intangibles (2021 - 2024)
Senti Biosciences' quarterly Amortizatization of Intangibles came in at $522000.0 in Q4 2024, down 64.99% quarter-over-quarter from $1.5 million in Q3 2024.
Senti Biosciences has reported Amortizatization of Intangibles for 4 years, with the latest figure at $522000.0 in Q4 2024.
- For the quarter ending Q4 2024, Amortizatization of Intangibles changed N/A year-over-year to $522000.0; the trailing twelve-month figure through Dec 2024 stood at $2.0 million (up 88.31% YoY), and the FY2024 full-year result was $2.0 million, up 88.31% from the prior year.
- Amortizatization of Intangibles for Q4 2024 stood at $522000.0, down from $1.5 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $2.0 million in Q3 2022, with the low at -$1.7 million in Q4 2022.
- Average Amortizatization of Intangibles over 4 years is $297888.9, with a median of $462000.0 recorded in 2023.
- Year-over-year, Amortizatization of Intangibles slumped 92.6% in 2023 and soared 894.0% in 2024.
- Tracing SNTI's Amortizatization of Intangibles over 4 years: stood at -$1.4 million in 2021, then slipped by 16.68% to -$1.7 million in 2022, then soared by 108.97% to $150000.0 in 2023, then jumped by 248.0% to $522000.0 in 2024.
- The last three Amortizatization of Intangibles figures came in at $522000.0 (Q4 2024), $1.5 million (Q3 2024), and $150000.0 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Senti Biosciences Holdings | 22.25 Mn | 22.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 522,000.00 |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.49 Mn |
| Sep 30, 2023 | 150,000.00 |
| Sep 30, 2023 | 150,000.00 |
| Jun 30, 2023 | 457,000.00 |
| Jun 30, 2023 | 457,000.00 |
| Mar 31, 2023 | 462,000.00 |
| Mar 31, 2023 | 462,000.00 |
| Dec 31, 2022 | -1.67 Mn |
| Dec 31, 2022 | -1.67 Mn |
| Sep 30, 2022 | 2.03 Mn |
| Sep 30, 2022 | 2.03 Mn |
| Dec 31, 2021 | -1.43 Mn |
| Dec 31, 2021 | -1.43 Mn |
| Sep 30, 2021 | 676,000.00 |
| Sep 30, 2021 | 676,000.00 |